{"id":"https://openalex.org/W2581960448","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.9011","title":"Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumor (GIST)","display_name":"Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumor (GIST)","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2581960448","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.9011","mag":"2581960448"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.9011","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.9011","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.9011","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068677359","display_name":"Robert G. Maki","orcid":"https://orcid.org/0000-0002-9853-2528","observed_orcids":["https://orcid.org/0000-0002-9853-2528"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. G. Maki","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040359760","display_name":"Jonathan Alfred Fletcher","orcid":"https://orcid.org/0000-0002-5109-2588","observed_orcids":["https://orcid.org/0000-0002-5109-2588"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. A. Fletcher","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091057405","display_name":"Michael Charles Heinrich","orcid":"https://orcid.org/0000-0003-3790-0478","observed_orcids":["https://orcid.org/0000-0003-3790-0478"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. C. Heinrich","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042802176","display_name":"Jeffrey A. Morgan","orcid":"https://orcid.org/0009-0006-6476-161X","observed_orcids":["https://orcid.org/0009-0006-6476-161X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. A. Morgan","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078289621","display_name":"Suzanne George","orcid":"https://orcid.org/0000-0002-1284-8493","observed_orcids":["https://orcid.org/0000-0002-1284-8493","https://orcid.org/0000-0002-8777-8530"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. George","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078038970","display_name":"Jayesh Desai","orcid":"https://orcid.org/0000-0003-4246-9344","observed_orcids":["https://orcid.org/0000-0003-4246-9344"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Desai","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048589703","display_name":"Kelly Scheu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Scheu","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050651568","display_name":"Christopher D.\ufffdM. Fletcher","orcid":"https://orcid.org/0000-0002-8053-9537","observed_orcids":["https://orcid.org/0000-0002-8053-9537"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. D. M. Fletcher","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051363304","display_name":"Charles M. Baum","orcid":"https://orcid.org/0000-0003-4481-1211","observed_orcids":["https://orcid.org/0000-0003-4481-1211"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Baum","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035376959","display_name":"George D. Demetri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. D. Demetri","raw_affiliation_strings":["Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Hosp, New York, NY; Brigham & Women\u2019s Hosp, Boston, MA; Oregon Health & Science Univ Cancer Institute, Portland, OR; Dana-Farber Cancer Inst, Boston, MA; Pfizer, La Jolla, CA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I180857899","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":109,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"9011","last_page":"9011"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9210000038146973},{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/kit-mutations","display_name":"KIT mutations","score":0.7850000262260437},{"id":"https://openalex.org/keywords/pdgfra-mutation","display_name":"PDGFRA mutation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.781000018119812},{"id":"https://openalex.org/keywords/flt3","display_name":"FLT3","score":0.7229999899864197},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5870000123977661},{"id":"https://openalex.org/keywords/lipase-elevation","display_name":"lipase elevation","score":0.949999988079071},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8690000176429749},{"id":"https://openalex.org/keywords/metastatic-gist","display_name":"metastatic GIST","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8889186978340149},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.6440764665603638},{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.5824052095413208},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5508157014846802},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5106266140937805},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5074426531791687},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.490225613117218},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4809405207633972},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.47533488273620605},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.46306127309799194},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.4525725543498993},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4455045759677887},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4247044026851654},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41114872694015503},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29071947932243347},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2809378206729889},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.22889766097068787},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.20475387573242188},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08852335810661316}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.9011","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.9011","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.9011","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2603969996","https://openalex.org/W2269193243","https://openalex.org/W2323304680","https://openalex.org/W1996537922","https://openalex.org/W2252961166","https://openalex.org/W2163973379","https://openalex.org/W2108215406","https://openalex.org/W2589086934","https://openalex.org/W2487815795","https://openalex.org/W2081016143"],"abstract_inverted_index":{"9011":[0],"Background:":[1],"Resistance":[2],"to":[3,104,111,174,238,297],"IM":[4,65,115],"eventually":[5],"develops":[6],"in":[7,20,67,95,118,179,274,283,295,301],"most":[8],"pts":[9,93,107,165,190,219,225,275],"with":[10,17,42,108,136,152,166,191,211,232,276],"metastatic":[11],"GIST":[12,68,109,189,278],"and":[13,45,60,123,183,248,279],"is":[14,35],"often":[15],"correlated":[16],"secondary":[18],"mutations":[19],"the":[21,161,205],"genes":[22],"encoding":[23],"KIT":[24],"or":[25,112,196,307,310],"platelet-derived":[26],"growth":[27],"factor":[28],"receptor":[29],"alpha":[30],"(PDGFRA)":[31],"tyrosine":[32,39],"kinases.":[33],"SU11248":[34,62,130,171,269],"an":[36],"oral":[37,134],"multi-targeted":[38],"kinase":[40],"inhibitor":[41],"both":[43],"anti-angiogenic":[44],"direct":[46],"anti-proliferative":[47],"activity":[48,273],"mediated":[49],"by":[50,70,132],"signal":[51],"blockade":[52],"of":[53,88,114,126,129,209,255,287,291],"several":[54],"kinases,":[55],"including":[56],"VEGFR2,":[57],"KIT,":[58],"PDGFRA,":[59],"FLT3.":[61],"can":[63],"overcome":[64],"resistance":[66],"caused":[69],"diverse":[71],"genomic":[72],"alterations":[73],"(Demetri":[74],"et":[75],"al.":[76],"Proc":[77],"ASCO":[78],"2004;":[79],"abstr":[80],"3001).":[81],"We":[82],"report":[83],"longer":[84],"term":[85],"clinical":[86,168,193,272],"results":[87],"a":[89,96,119,153,176,284],"continuation":[90,177,206],"study":[91,122],"accruing":[92],"treated":[94],"prior":[97],"phase":[98,120,141,162],"I/II":[99,121,163],"study.":[100],"Methods:":[101],"From":[102],"07/02":[103],"07/04,":[105],"97":[106],"resistant":[110],"intolerant":[113],"were":[116,172,185],"enrolled":[117,203],"received":[124],"one":[125],"three":[127],"schedules":[128],"administered":[131],"daily":[133,148],"dosing":[135,138],"intermittent":[137],"breaks.":[139],"The":[140],"II":[142],"schedule":[143],"chosen":[144],"was":[145],"50":[146],"mg/d":[147],"for":[149,252],"4":[150,249],"weeks":[151],"2":[154],"week":[155],"break.":[156],"After":[157],"6":[158,200,224],"months":[159],"on":[160,204,221],"study,":[164,222],"continued":[167,192],"benefit":[169,194,282],"from":[170],"allowed":[173],"enter":[175],"protocol":[178],"which":[180],"tumor":[181,292],"progression":[182,239],"safety":[184],"assessed.":[186],"Results:":[187],"32":[188],"(PR":[195],"stable":[197],"disease":[198,234],">":[199],"months)":[201],"have":[202],"protocol.":[207],"As":[208],"12/04,":[210],"median":[212,236],"treatment":[213],"time":[214,237],"over":[215],"1":[216],"year,":[217],"26":[218],"remain":[220],"while":[223],"developed":[226],"progressive":[227],"disease.":[228],"For":[229],"22":[230],"patients":[231,256],"RECIST-evaluable":[233],"neither":[235],"nor":[240],"overall":[241],"survival":[242],"has":[243],"been":[244],"reached.":[245],"Grade":[246],"3":[247],"adverse":[250],"events":[251],"this":[253,299],"cohort":[254],"included:":[257],"hypertension":[258],"(16%),":[259],"asymptomatic":[260],"lipase":[261],"elevation":[262],"(15%),":[263],"neutropenia":[264],"(14%),":[265],"fatigue":[266],"(11%).":[267],"Conclusions:":[268],"shows":[270],"promising":[271],"IM-resistant":[277],"provides":[280],"durable":[281],"selected":[285],"population":[286],"pts.":[288],"Molecular":[289],"analyses":[290],"genotype":[293],"are":[294],"progress":[296],"understand":[298],"subset":[300],"more":[302],"detail.":[303],"Author":[304],"Disclosure":[305],"Employment":[306],"Leadership":[308],"Consultant":[309],"Advisory":[311],"Role":[312],"Stock":[313],"Ownership":[314],"Honoraria":[315],"Research":[316],"Funding":[317],"Expert":[318],"Testimony":[319],"Other":[320],"Remuneration":[321],"Pfizer":[322,326,327],"Novartis":[323,324],"Novartis,":[325]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2017-02-03T00:00:00"}